Infectious Diseases (except HIV/AIDS)
-
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
This article has 54 authors:Reviewed by ScreenIT
-
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting
This article has 6 authors:Reviewed by ScreenIT
-
COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after Omicron emerged in the US
This article has 6 authors:Reviewed by ScreenIT
-
Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection
This article has 32 authors:Reviewed by ScreenIT
-
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
This article has 19 authors:Reviewed by ScreenIT
-
An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial
This article has 58 authors:Reviewed by ScreenIT
-
SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway
This article has 14 authors:Reviewed by ScreenIT
-
Immunity post-COVID-19 recovery boosts the antibody immune response to SARS-CoV-2 vaccination
This article has 20 authors:Reviewed by ScreenIT
-
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19
This article has 36 authors:Reviewed by ScreenIT
-
Four doses of the inactivated SARS-CoV-2 vaccine redistribute humoral immune responses away from the Receptor Binding Domain
This article has 14 authors:Reviewed by ScreenIT